Study Name: Open-Label Extension Study of GSK1605786A
31 locations found
- GSK Investigational Site
Location: Little Rock, Arizona 72205
- GSK Investigational Site
Location: La Jolla, California 92093
- GSK Investigational Site
Location: San Diego, California 92103
- GSK Investigational Site
Location: San Francisco, California 94115
- GSK Investigational Site
Location: Lakewood, Colorado 80215
- GSK Investigational Site
Location: Littleton, Colorado 80120
- GSK Investigational Site
Location: Hamden, Connecticut 06518
- GSK Investigational Site
Location: Port Orange, Florida 32127
- GSK Investigational Site
Location: Atlanta, Georgia 30342
- GSK Investigational Site
Location: Chicago, Illinois 60637
- GSK Investigational Site
Location: Indianapolis, Indiana 46237
- GSK Investigational Site
Location: Hammond, Louisiana 70403
- GSK Investigational Site
Location: Monroe, Louisiana 71201
- GSK Investigational Site
Location: Chevy Chase, Maryland 20815
- GSK Investigational Site
Location: Boston, Massachusetts 02114
- GSK Investigational Site
Location: Ann Arbor, Michigan 48109
- GSK Investigational Site
Location: Chesterfield, Michigan 48047
- GSK Investigational Site
Location: Troy, Michigan 48098
- GSK Investigational Site
Location: Rochester, Minnesota 55905
- GSK Investigational Site
Location: Great Neck, New York 11021
- GSK Investigational Site
Location: Chapel Hill, North Carolina 27599
- GSK Investigational Site
Location: Durham, North Carolina 27710
- GSK Investigational Site
Location: Columbus, Ohio 43215
- GSK Investigational Site
Location: Tulsa, Oklahoma 74135
- GSK Investigational Site
Location: Portland, Oregon 97225
- GSK Investigational Site
Location: Nashville, Tennessee 37212
- GSK Investigational Site
Location: Ogden, Utah 84405
- GSK Investigational Site
Location: Christiansburg, Virginia 24073
- GSK Investigational Site
Location: Danville, Virginia 24541
- GSK Investigational Site
Location: Seattle, Washington 98101
- GSK Investigational Site
Location: Seattle, Washington 98195
|